OncoCyte Corporation - stock earnings

OCX Quarterly earnings

DateEarningsRevenue
2023Q3 -6.5 million USD 429000 USD
2023Q2 -8.3 million USD 463000 USD
2023Q1 -45.3 million USD 297000 USD
2022Q4 -45.0 million USD 274000 USD
2022Q3 -9.4 million USD 67000 USD
2022Q2 -8.0 million USD 237000 USD
2022Q1 -10.7 million USD 380000 USD
2021Q4 -35.9 million USD 3.6 million USD
2021Q3 -13.8 million USD 984000 USD
2021Q2 -10.5 million USD 2.0 million USD
2021Q1 -3.9 million USD 1.1 million USD
2020Q4 -6.3 million USD 503000 USD
2020Q3 -6.8 million USD 555000 USD
2020Q2 -9.1 million USD 143000 USD
2020Q1 -7.7 million USD 16000 USD
2019Q4 -8.0 million USD ? USD
2019Q3 -5.2 million USD ? USD
2019Q2 -5.4 million USD ? USD
2019Q1 -4.5 million USD ? USD
2018Q4 -4.5 million USD ? USD
2018Q3 -3.0 million USD ? USD
2018Q2 -4.5 million USD ? USD
2018Q1 -4.0 million USD ? USD
2017Q4 -4.0 million USD ? USD
2017Q3 -6.9 million USD ? USD
2017Q2 -3.8 million USD ? USD
2017Q1 -4.7 million USD ? USD
2016Q4 -3.1 million USD ? USD
2016Q3 -2.6 million USD ? USD
2016Q2 -2.5 million USD ? USD
2016Q1 -2.9 million USD ? USD
2015Q4 -3.5 million USD ? USD
2015Q3 -2.4 million USD ? USD
2015Q2 -1.4 million USD ? USD
2015Q1 -1.4 million USD ? USD
2014Q4 -1.5 million USD ? USD

OCX Yearly earnings

DateEarningsRevenue
2023 -56.8 million USD 1.5 million USD
2022 -73.4 million USD 958000 USD
2021 -64.1 million USD 7.7 million USD
2020 -29.9 million USD 1.2 million USD
2019 -22.3 million USD 16000 USD
2018 -15.8 million USD ? USD
2017 -19.4 million USD ? USD
2016 -11.2 million USD ? USD
2015 -8.7 million USD ? USD
2014 -5.0 million USD ? USD
2013 -3.5 million USD ? USD

OCX

Price: $2.55

52 week price:
2.08
6.80

Earnings Per Share: -3.37 USD

P/E Ratio: -0.89

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 412400

Market Capitalization: 22.4 million

Links: